Related Experiment Video
Updated: Aug 8, 2025

10:54
Extraction of Plant-based Capsules for Microencapsulation Applications
Published on: November 9, 2016
12.1K
Identification of Drug Compounds for Capsular Contracture Based on Text Mining and Deep Learning
Yeheng Lu1, Zhiwei Chen2, Yuyan Pan1
1From the Department of Plastic Surgery, Zhongshan Hospital.
Plastic and Reconstructive Surgery
|March 2, 2023
Summary
This study identifies potential non-surgical drug therapies for breast implant capsular contracture using computational methods. Promising drug candidates targeting key genes were discovered, offering new treatment avenues.
Area of Science:
- Biomedical research
- Computational drug discovery
- Genomics and bioinformatics
Background:
- Capsular contracture is a frequent complication of breast implants with unclear causes.
- Current non-surgical treatments for capsular contracture lack proven effectiveness.
Purpose of the Study:
- To explore novel drug therapies for capsular contracture using computational approaches.
- To identify potential non-surgical treatments for this common breast implant complication.
Main Methods:
- Utilized text mining and bioinformatics tools (GeneCodis, STRING, Cytoscape) to identify genes associated with capsular contracture.
- Screened drug databases (Pharmaprojects) and employed machine learning (DeepPurpose) to predict drug-target interactions and binding affinity.
Main Results:
- Identified 55 relevant genes, narrowing down to eight candidate genes through pathway and interaction analyses.
- Selected 100 drugs targeting these genes, with seven candidates showing the highest predicted binding affinity, including specific antagonists and agonists.
Conclusions:
- Computational methods, including text mining and DeepPurpose, show promise for discovering non-surgical treatments for capsular contracture.
- This approach facilitates the identification of novel therapeutic strategies for managing breast implant complications.
Related Concept Videos
Drug Nomenclature
1.8K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.8K
Drug Discovery: Overview
8.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.2K
Peptide Identification Using Tandem Mass Spectrometry
6.6K
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
6.6K
Drug Delivery: Overview
345
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
345
Drug-Receptor Bonds
3.0K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
3.0K
Drug Distribution: Tissue Binding
2.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.7K

